Engineered Saccharomyces cerevisiae for de novo δ-tocotrienol biosynthesis
- 23 March 2023
- journal article
- research article
- Published by Springer Nature in Systems Microbiology and Biomanufacturing
- Vol. 4 (1) , 150-164
Abstract
No abstract availableKeywords
Funding Information
- Key Research and Development Program of China (2022YFC2106100, 2018YFA0900300)
- National Natural Science Foundation of China (32021005)
- Fundamental Research Funds for the Central Universities (JUSRP222007, JUSRP622004)
This publication has 57 references indexed in Scilit:
- Retinoid production using metabolically engineered Escherichia coli with a two-phase culture systemMicrobial Cell Factories, 2011
- Diversion of Flux toward Sesquiterpene Production inSaccharomyces cerevisiaeby Fusion of Host and Heterologous EnzymesApplied and Environmental Microbiology, 2011
- Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseasesBiochemical Pharmacology, 2010
- Overproduction of Geranylgeraniol by Metabolically Engineered Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2009
- DNA assembler, an in vivo genetic method for rapid construction of biochemical pathwaysNucleic Acids Research, 2008
- Biosynthesis of the Vitamin E Compound δ‐Tocotrienol in Recombinant Escherichia coli CellsChemBioChem, 2008
- Differential distribution of tocopherols and tocotrienols in photosynthetic and non-photosynthetic tissuesPhytochemistry, 2006
- Tocotrienols: Vitamin E beyond tocopherolsLife Sciences, 2006
- Chemistry and biology of vitamin EMolecular Nutrition & Food Research, 2004
- Endoplasmic reticulum localization of Sec12p is achieved by two mechanisms: Rer1p-dependent retrieval that requires the transmembrane domain and Rer1p-independent retention that involves the cytoplasmic domain.Journal of Cell Biology, 1996